Announcements & Media Coverage

Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”)   Hemogenyx Pharmaceuticals Announces Clinical Hold on IND for HEMO-CAR-T   Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company has received a notice from the U.S. Food and Drug Administration (“FDA”) regarding the Investigational New Drug...